{
  "id": 19234350,
  "title": "FDA-approved drug kills cancer cells in lab by disrupting cellular recycling",
  "url": "https://urgent.news/2026/11/09/fda-approved-drug-kills-cancer-cells-in-lab-by-disrupting-cellular",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-09T22:10:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-fda-drug-cancer-cells-lab.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Researchers from VCU Massey Comprehensive Cancer Center recently demonstrated that the inhibition of glucosylceramide synthase (GCS) can cause death in cancer cells that is independent of changes in pro-death ceramide levels. The findings, which were recently published in Cell Death Discovery, showed that using eliglustat, an FDA-approved drug, induced cell death in several cancer cell lines.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}